Point72 Asset Management’s CONMED CNMD Stock Holding History

Point72 Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28M	Sell	69,585 -64,529	-48%	-$2.32M	﹤0.01%	2309
2026 Q1	$4.74M	Buy	134,114 +3,156	+2%	+$128K	0.01%	1741
2025 Q4	$5.32M	Buy	+130,958	New	+$5.7M	0.01%	1803
2024 Q1	–	Sell	-110,779	Closed	-$9.87M	–	2247
2023 Q4	$12.1M	Buy	+110,779	New	+$11.5M	0.03%	627
2022 Q3	–	Sell	-5,040	Closed	-$483K	–	1438
2022 Q2	$483K	Sell	5,040 -87,131	-95%	-$10.5M	﹤0.01%	1191
2022 Q1	$13.7M	Buy	92,171 +63,009	+216%	+$8.8M	0.05%	429
2021 Q4	$4.13M	Sell	29,162 -54,549	-65%	-$7.73M	0.02%	708
2021 Q3	$11M	Buy	+83,711	New	+$11M	0.05%	462
2021 Q1	–	Sell	-58,556	Closed	-$6.56M	–	991
2020 Q4	$6.56M	Sell	58,556 -788,981	-93%	-$74.7M	0.03%	533
2020 Q3	$66.7M	Sell	847,537 -295,116	-26%	-$24.1M	0.34%	66
2020 Q2	$82.3M	Buy	1,142,653 +665,606	+140%	+$46.3M	0.54%	35
2020 Q1	$27.3M	Buy	477,047 +372,250	+355%	+$34.3M	0.22%	128
2019 Q4	$11.7M	Buy	104,797 +35,031	+50%	+$3.73M	0.06%	353
2019 Q3	$6.71M	Sell	69,766 -670,310	-91%	-$62.9M	0.04%	414
2019 Q2	$63.3M	Sell	740,076 -8,335	-1%	-$685K	0.33%	71
2019 Q1	$62.3M	Buy	748,411 +587,311	+365%	+$42.7M	0.28%	82
2018 Q4	$10.3M	Buy	+161,100	New	+$11M	0.05%	407
2016 Q3	–	Sell	-284,800	Closed	-$13.6M	–	728
2016 Q2	$13.6M	Buy	+284,800	New	+$12.1M	0.09%	247
2014 Q3	–	Sell	-27,100	Closed	-$1.2M	–	664
2014 Q2	$1.2M	Buy	+27,100	New	+$1.23M	0.01%	599

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Point72 Asset Management's CNMD Position: Q2 2026 in Review

Point72 Asset Management reduced its CONMED (CNMD) stake by 48% in Q2 2026, selling an estimated $2.32M and leaving 69,585 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2309.

Point72 Asset Management first reported a position in CNMD in Q2 2014 and has held it in 19 quarters since. The position peaked at $82.3M in Q2 2020. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Point72 Asset Management held 69,585 shares of CONMED worth $2.28M as of Q2 2026.
Point72 Asset Management sold 64,529 CONMED shares in Q2 2026, an estimated $2.32M.
CONMED made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2309 holding.
Point72 Asset Management first reported a position in CONMED in Q2 2014 and has held it in 19 quarters since.
Point72 Asset Management's CONMED position peaked at $82.3M in Q2 2020.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.